How scientists are using gene networks to fight the devastating muscle wasting of pancreatic cancer.
Scientists investigate a suspected culprit in the devastating muscle loss that weakens pancreatic cancer patients, with surprising findings about the PDK4 enzyme.
Groundbreaking research reveals how tumor-derived IGFBP-3 drives muscle wasting in pancreatic cancer patients through metabolic hijacking.
Discover how Fra-1 protein orchestrates muscle wasting in cancer cachexia through mitochondrial dysfunction and apoptosis pathways.